Immunomodulation therapy offers new molecular strategies to treat UTI.


Journal

Nature reviews. Urology
ISSN: 1759-4820
Titre abrégé: Nat Rev Urol
Pays: England
ID NLM: 101500082

Informations de publication

Date de publication:
07 2022
Historique:
accepted: 22 04 2022
pubmed: 23 6 2022
medline: 8 7 2022
entrez: 22 6 2022
Statut: ppublish

Résumé

Innovative solutions are needed for the treatment of bacterial infections, and a range of antibacterial molecules have been explored as alternatives to antibiotics. A different approach is to investigate the immune system of the host for new ways of making the antibacterial defence more efficient. However, the immune system has a dual role as protector and cause of disease: in addition to being protective, increasing evidence shows that innate immune responses can become excessive and cause acute symptoms and tissue pathology during infection. This role of innate immunity in disease suggests that the immune system should be targeted therapeutically, to inhibit over-reactivity. The ultimate goal is to develop therapies that selectively attenuate destructive immune response cascades, while augmenting the protective antimicrobial defence but such treatment options have remained underexplored, owing to the molecular proximity of the protective and destructive effects of the immune response. The concept of innate immunomodulation therapy has been developed successfully in urinary tract infections, based on detailed studies of innate immune activation and disease pathogenesis. Effective, disease-specific, immunomodulatory strategies have been developed by targeting specific immune response regulators including key transcription factors. In acute pyelonephritis, targeting interferon regulatory factor 7 using small interfering RNA or treatment with antimicrobial peptide cathelicidin was protective and, in acute cystitis, targeting overactive effector molecules such as IL-1β, MMP7, COX2, cAMP and the pain-sensing receptor NK1R has been successful in vivo. Furthermore, other UTI treatment strategies, such as inhibiting bacterial adhesion and vaccination, have also shown promise.

Identifiants

pubmed: 35732832
doi: 10.1038/s41585-022-00602-4
pii: 10.1038/s41585-022-00602-4
pmc: PMC9214477
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

419-437

Informations de copyright

© 2022. Springer Nature Limited.

Références

Infect Immun. 1984 Dec;46(3):839-44
pubmed: 6389367
Infect Immun. 1991 Mar;59(3):1153-61
pubmed: 1671776
Science. 1989 Jan 13;243(4888):226-9
pubmed: 2911736
Urology. 2009 Feb;73(2):258-62
pubmed: 19036420
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22439-44
pubmed: 20018753
J Exp Med. 1996 Mar 1;183(3):1037-44
pubmed: 8642245
Infect Immun. 2007 Aug;75(8):3941-9
pubmed: 17517861
J Clin Invest. 2021 Sep 15;131(18):
pubmed: 34523610
J Immunol. 1987 May 15;138(10):3475-80
pubmed: 3553327
Mucosal Immunol. 2013 Nov;6(6):1041-53
pubmed: 24064671
Expert Rev Clin Immunol. 2014 Jan;10(1):7-18
pubmed: 24308832
Nat Rev Cancer. 2002 Oct;2(10):764-76
pubmed: 12360279
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80
pubmed: 25675528
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33653961
J Infect Dis. 2001 Mar 1;183 Suppl 1:S56-60
pubmed: 11171016
Microbiol Immunol. 2011 Apr;55(4):217-23
pubmed: 21272062
J Clin Invest. 2015 Nov 2;125(11):4171-85
pubmed: 26524590
Int Rev Immunol. 2011 Feb;30(1):16-34
pubmed: 21235323
Int J Immunogenet. 2007 Dec;34(6):399-405
pubmed: 18001294
Nature. 2000 Jun 8;405(6787):694-7
pubmed: 10864327
J Clin Microbiol. 2010 Mar;48(3):966-8
pubmed: 20042631
N Engl J Med. 1993 Oct 28;329(18):1328-34
pubmed: 8413414
Curr Opin Microbiol. 2008 Feb;11(1):66-73
pubmed: 18243043
Nat Rev Urol. 2010 Aug;7(8):430-41
pubmed: 20647992
Pediatr Nephrol. 2008 Mar;23(3):429-33
pubmed: 18040727
PLoS Pathog. 2016 Oct 12;12(10):e1005848
pubmed: 27732661
Mol Microbiol. 1998 Sep;29(5):1297-306
pubmed: 9767596
J Clin Microbiol. 1987 Dec;25(12):2253-7
pubmed: 2892855
PLoS Pathog. 2019 Jun 10;15(6):e1007671
pubmed: 31181116
JCI Insight. 2019 May 30;5:
pubmed: 31145099
BMJ. 2017 Nov 7;359:j4784
pubmed: 29113968
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9630-5
pubmed: 8790381
Infect Immun. 1991 Dec;59(12):4357-62
pubmed: 1682260
J Immunol. 1999 Mar 1;162(5):3037-44
pubmed: 10072556
Nature. 1982 Aug 5;298(5874):560-2
pubmed: 7048106
Infect Immun. 1983 May;40(2):529-33
pubmed: 6341240
J Infect Dis. 1995 Mar;171(3):625-31
pubmed: 7876609
J Exp Med. 2000 Sep 18;192(6):881-90
pubmed: 10993918
Arch Pediatr Adolesc Med. 2000 Apr;154(4):339-45
pubmed: 10768669
Infect Immun. 1982 Jul;37(1):286-91
pubmed: 6125477
Nat Med. 2006 Jun;12(6):636-41
pubmed: 16751768
Infect Immun. 2006 Jan;74(1):594-601
pubmed: 16369016
Int J Antimicrob Agents. 1994 Jun;4(2):89-93
pubmed: 18611594
J Immunol. 2007 Apr 15;178(8):4717-20
pubmed: 17404249
Infect Immun. 1990 Sep;58(9):3073-7
pubmed: 2201644
J Immunol. 2010 Feb 15;184(4):2065-75
pubmed: 20083670
EBioMedicine. 2014 Oct 24;1(1):46-57
pubmed: 26125048
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13468-13473
pubmed: 27821778
PLoS One. 2011 Mar 04;6(3):e17360
pubmed: 21394197
Nat Biotechnol. 2021 Jun;39(6):754-764
pubmed: 33574609
J Immunol. 2001 Jan 15;166(2):1148-55
pubmed: 11145696
Nat Immunol. 2020 Jun;21(6):671-683
pubmed: 32424366
J Infect Dis. 2000 Feb;181(2):774-8
pubmed: 10669375
J Infect Dis. 1981 Mar;143(3):404-12
pubmed: 7014730
Inflammation. 2019 Feb;42(1):246-254
pubmed: 30196377
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8110-5
pubmed: 10393956
N Engl J Med. 2003 Jul 17;349(3):259-66
pubmed: 12867610
Lancet. 1976 Sep 4;1(7984):490-2
pubmed: 74461
J Infect. 1988 Mar;16(2):147-52
pubmed: 2895151
J Mol Med (Berl). 2008 Jan;86(1):37-47
pubmed: 17805504
J Infect Dis. 1979 Mar;139(3):329-32
pubmed: 376757
J Infect Dis. 1988 Jul;158(1):29-35
pubmed: 3292665
Nat Rev Microbiol. 2004 Feb;2(2):123-40
pubmed: 15040260
Infect Immun. 2014 Apr;82(4):1572-8
pubmed: 24452682
Mucosal Immunol. 2017 Jul;10(4):924-935
pubmed: 27966556
PLoS Pathog. 2007 Jul;3(7):e100
pubmed: 17630833
J Immunol. 1994 Jul 15;153(2):712-23
pubmed: 8021507
Clin Infect Dis. 1998 Aug;27 Suppl 1:S32-41
pubmed: 9710669
N Engl J Med. 2013 Aug 29;369(9):819-29
pubmed: 23984729
Kidney Int. 2008 Jul;74(1):81-90
pubmed: 18401338
Mucosal Immunol. 2016 Jan;9(1):124-36
pubmed: 25993444
Kidney Int. 2018 Jun;93(6):1320-1329
pubmed: 29475562
Cell Microbiol. 2008 Dec;10(12):2568-78
pubmed: 18754853
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263309
J Infect Dis. 2001 Mar 1;183 Suppl 1:S84-6
pubmed: 11171023
Nat Struct Mol Biol. 2004 May;11(5):394-403
pubmed: 15114340
J Urol. 1997 Jun;157(6):2049-52
pubmed: 9146577
mBio. 2020 Apr 28;11(2):
pubmed: 32345645
Ther Deliv. 2013 Jan;4(1):45-57
pubmed: 23323780
J Infect Dis. 2007 Apr 15;195(8):1227-34
pubmed: 17357062
J Hypertens. 2014 Aug;32(8):1658-64; discussion 1664
pubmed: 24875180
PLoS One. 2009 Jun 22;4(6):e5990
pubmed: 19543401
Infect Immun. 2012 Dec;80(12):4115-22
pubmed: 22966046
Folia Microbiol (Praha). 2014 Jul;59(4):307-13
pubmed: 24449078
Nat Rev Microbiol. 2020 Apr;18(4):211-226
pubmed: 32071440
BMC Urol. 2009 Nov 12;9:16
pubmed: 19909543
Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F43-F53
pubmed: 27760770
J Urol. 2014 Aug;192(2):600-6
pubmed: 24681329
Am J Physiol Renal Physiol. 2014 Oct 1;307(7):F869-80
pubmed: 25143453
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
Cell Host Microbe. 2013 Dec 11;14(6):664-74
pubmed: 24331464
Hum Vaccin Immunother. 2021 May 4;17(5):1262-1270
pubmed: 33325785
Int J Immunogenet. 2012 Aug;39(4):338-45
pubmed: 22325052
J Urol. 1999 Sep;162(3 Pt 1):815-20
pubmed: 10458387
J Immunol. 2000 Nov 1;165(9):5287-94
pubmed: 11046063
Urol Res. 1983;11(2):97-102
pubmed: 6346629
Nat Rev Immunol. 2007 Nov;7(11):862-74
pubmed: 17948019
J Urol. 1993 Apr;149(4):922-5
pubmed: 8455276
Clin Infect Dis. 1993 Sep;17(3):448-56
pubmed: 8105983
Nat Rev Urol. 2020 Aug;17(8):439-458
pubmed: 32661333
Infect Immun. 1977 Aug;17(2):286-9
pubmed: 70410
Acta Paediatr Scand Suppl. 1970;206:Suppl 206:78+
pubmed: 5277006
Mol Cell. 2002 Nov;10(5):1033-43
pubmed: 12453412
J Pediatr. 1986 Sep;109(3):416-21
pubmed: 3746529
BMJ. 2019 Feb 27;364:l525
pubmed: 30814048
PLoS Pathog. 2015 Apr 30;11(4):e1004818
pubmed: 25927232
BMC Infect Dis. 2012 Oct 26;12:273
pubmed: 23101431
Int J Biochem Cell Biol. 2007;39(10):1776-80
pubmed: 17714976
Kidney Int. 2005 Jan;67(1):103-10
pubmed: 15610233
J Clin Invest. 1998 Apr 15;101(8):1633-42
pubmed: 9541493
J Infect Dis. 1992 Sep;166(3):653-6
pubmed: 1500753
Kidney Int. 1975 Nov;8(5):316-9
pubmed: 1104969
Clin Microbiol Rev. 1991 Jan;4(1):80-128
pubmed: 1672263
Nature. 1996 May 2;381(6577):77-80
pubmed: 8609993
Infect Immun. 1990 Jul;58(7):2056-60
pubmed: 2194956
J Clin Invest. 2021 Feb 15;131(4):
pubmed: 33320835
Curr Opin Microbiol. 2001 Oct;4(5):500-8
pubmed: 11587924
J Microbiol Methods. 2009 Aug;78(2):131-5
pubmed: 19426766
Scand J Immunol. 1985 Apr;21(4):305-13
pubmed: 3890147
Nature. 2001 Apr 26;410(6832):1099-103
pubmed: 11323673
Sci Transl Med. 2016 Apr 27;8(336):336ra59
pubmed: 27122612
Invest Urol. 1969 Mar;6(5):520-6
pubmed: 4887493
Ann Med. 2001 Dec;33(9):563-70
pubmed: 11817650
Dev Dyn. 2009 Feb;238(2):405-14
pubmed: 19161241
Diagn Microbiol Infect Dis. 2014 Mar;78(3):255-62
pubmed: 24360267
Transpl Int. 2008 Jun;21(6):572-80
pubmed: 18363573
Infect Immun. 1987 Feb;55(2):373-80
pubmed: 2879794
PLoS Med. 2018 May 15;15(5):e1002569
pubmed: 29763434
Infect Immun. 2008 Jul;76(7):2978-90
pubmed: 18443089
Amino Acids. 2014 Jul;46(7):1727-50
pubmed: 24705689
Kidney Int. 2011 Jul;80(2):174-80
pubmed: 21525852
Nature. 1987 Jul 2-8;328(6125):84-7
pubmed: 2885755
Infect Immun. 2018 Aug 22;86(9):
pubmed: 29891542
Mol Immunol. 2004 Feb;40(12):845-59
pubmed: 14698223
Blood. 2018 May 3;131(18):2007-2015
pubmed: 29514782
Cell Host Microbe. 2007 Jun 14;1(4):287-98
pubmed: 17710226
Nat Rev Immunol. 2019 Jul;19(7):433-447
pubmed: 30874629
Nature. 2017 Jun 22;546(7659):528-532
pubmed: 28614296
J Urol. 2004 Apr;171(4):1682-5
pubmed: 15017266
Infect Immun. 1985 Nov;50(2):370-7
pubmed: 2865209
mSphere. 2018 Jul 25;3(4):
pubmed: 30045966
J Am Chem Soc. 2014 Dec 10;136(49):16958-61
pubmed: 25434769
J Biol Chem. 2006 May 26;281(21):14644-53
pubmed: 16567801
J Pediatr Urol. 2017 Dec;13(6):593.e1-593.e10
pubmed: 28716390
N Engl J Med. 2005 May 19;352(20):2047-8
pubmed: 15901857
J Clin Invest. 2013 Jun;123(6):2366-79
pubmed: 23728172
Antimicrob Agents Chemother. 1993 Nov;37(11):2255-60
pubmed: 8285603
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6985-90
pubmed: 23569230
Nat Med. 2007 May;13(5):625-30
pubmed: 17417648
Lancet Infect Dis. 2017 May;17(5):528-537
pubmed: 28238601
Cell. 2014 Jan 30;156(3):456-68
pubmed: 24485454
Nat Rev Urol. 2021 Aug;18(8):468-486
pubmed: 34131331
Ann N Y Acad Sci. 2003 Dec;1002:63-71
pubmed: 14751823
Infect Immun. 1987 May;55(5):1224-32
pubmed: 3552994
Nature. 1977 Feb 17;265(5595):623-5
pubmed: 323718
Lancet Rheumatol. 2020 Jul;2(7):e393-e400
pubmed: 32835245
BJU Int. 2019 May;123(5):753-768
pubmed: 30378242
Front Cell Infect Microbiol. 2015 Jun 03;5:50
pubmed: 26090341
Curr Opin Immunol. 2000 Feb;12(1):20-6
pubmed: 10679411
Trends Immunol. 2021 Mar;42(3):248-260
pubmed: 33536141
Arch Intern Med. 2003 Oct 27;163(19):2393; author reply 2393-4
pubmed: 14581259
J Pediatr. 2010 Dec;157(6):1038-1040.e1
pubmed: 20869067
Acta Paediatr. 2012 Oct;101(10):1018-31
pubmed: 22784016
J Clin Invest. 1993 Aug;92(2):780-5
pubmed: 8349817
BMJ. 2015 Dec 23;351:h6544
pubmed: 26698878
J Urol. 2007 Feb;177(2):450-6
pubmed: 17222607
Nature. 2002 Nov 21;420(6913):324-9
pubmed: 12447441
Microbiol Rev. 1983 Dec;47(4):510-50
pubmed: 6363898
Pediatr Nephrol. 2003 Apr;18(4):362-5
pubmed: 12700963
Microb Pathog. 2017 Sep;110:477-483
pubmed: 28754265
Toxicon. 2018 Jul;149:45-53
pubmed: 29056305
Front Cell Infect Microbiol. 2017 Apr 06;7:113
pubmed: 28428949
Immunity. 2011 Dec 23;35(6):1023-34
pubmed: 22195750
Infect Immun. 1989 Nov;57(11):3383-8
pubmed: 2680971
N Engl J Med. 1964 Aug 27;271:445-7
pubmed: 14171815
Eur Urol. 2008 Jan;53(1):60-7
pubmed: 17900797
J Bacteriol. 2007 May;189(9):3532-46
pubmed: 17351047
N Engl J Med. 1986 May 1;314(18):1152-6
pubmed: 3960089
J Infect Dis. 2010 Apr 15;201(8):1240-9
pubmed: 20225955
Clin Diagn Lab Immunol. 2005 Dec;12(12):1358-63
pubmed: 16339057
PLoS Pathog. 2010 Sep 23;6(9):e1001109
pubmed: 20886096
Curr Opin Urol. 2017 Mar;27(2):133-137
pubmed: 27846034
Rheumatol Int. 1998;18(3):97-102
pubmed: 9833249
J Exp Med. 2005 Mar 21;201(6):1007-18
pubmed: 15767367
Am J Pathol. 2000 Mar;156(3):775-80
pubmed: 10702392
J Urol. 1999 Jan;161(1):338-41
pubmed: 10037434
Nat Rev Microbiol. 2021 May;19(5):287-302
pubmed: 33542518
Infect Immun. 2002 Jun;70(6):3053-60
pubmed: 12010997
Br J Urol. 1990 Jan;65(1):6-9
pubmed: 2178724
Infect Immun. 1983 Apr;40(1):265-72
pubmed: 6131870
J Urol. 2013 Jan;189(1):343-51
pubmed: 23174261
J Cell Biol. 1991 Jan;112(1):13-25
pubmed: 1986001
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9827-32
pubmed: 8790416
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
J Clin Invest. 2014 Jul;124(7):2963-76
pubmed: 24937428
J Clin Invest. 2012 Oct;122(10):3476-89
pubmed: 22945633
J Biol Chem. 2001 Mar 30;276(13):9924-30
pubmed: 11134021
Nat Rev Urol. 2010 Dec;7(12):653-60
pubmed: 21139641
Infect Immun. 2007 Jun;75(6):2679-88
pubmed: 17513849
Trends Microbiol. 1995 Jul;3(7):266-70
pubmed: 7551639
Clin Sci (Lond). 2006 Jan;110(1):47-58
pubmed: 16336204
Arthritis Res Ther. 2013;15(5):R123
pubmed: 24432362
J Clin Invest. 2021 Sep 15;131(18):
pubmed: 34523612
Ann Rheum Dis. 2006 Aug;65(8):1006-12
pubmed: 16396977
PLoS Pathog. 2010 Sep 23;6(9):e1001120
pubmed: 20886104
N Engl J Med. 2012 Mar 15;366(11):1028-37
pubmed: 22417256
Urology. 2008 Jun;71(6):1085-90
pubmed: 18538691
JAMA. 2015 Mar 24-31;313(12):1207-8
pubmed: 25803342
Nat Med. 2008 Apr;14(4):399-406
pubmed: 18327267
J Infect Dis. 2001 Aug 1;184(3):301-7
pubmed: 11443555
Urology. 1997 May;49(5A Suppl):2-9
pubmed: 9145997
PLoS Pathog. 2009 Sep;5(9):e1000586
pubmed: 19806177
Lancet Rheumatol. 2021 Oct;3(10):e690-e697
pubmed: 34396156
Nat Commun. 2016 Mar 14;7:10791
pubmed: 26972847
Sci Transl Med. 2011 Nov 16;3(109):109ra115
pubmed: 22089451
Nat Rev Urol. 2011 Jul 12;8(8):449-68
pubmed: 21750501
N Engl J Med. 2013 May 2;368(18):1685-94
pubmed: 23534542
PLoS Pathog. 2015 Jul 16;11(7):e1005044
pubmed: 26182347
Allergy. 2020 Apr;75(4):841-852
pubmed: 31833571
PLoS One. 2009 Dec 15;4(12):e8300
pubmed: 20016852
Pediatr Infect Dis J. 2011 Apr;30(4):309-14
pubmed: 21042230
PLoS Pathog. 2012;8(4):e1002619
pubmed: 22577358
Eur J Immunol. 2006 Feb;36(2):267-77
pubmed: 16385628
Ann N Y Acad Sci. 1994 Aug 15;730:162-81
pubmed: 7915893
Crit Care Med. 2006 Jan;34(1):15-21
pubmed: 16374151
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32747356
Expert Opin Investig Drugs. 2009 Dec;18(12):1843-64
pubmed: 19938899
Infect Immun. 1993 Feb;61(2):602-9
pubmed: 8423089
Infect Immun. 1997 Aug;65(8):3451-6
pubmed: 9234811
Hong Kong Med J. 2014 Aug;20(4):285-9
pubmed: 24625386
BMC Med. 2010 May 26;8:30
pubmed: 20504298
Eur Urol Open Sci. 2021 Aug 06;31:49-58
pubmed: 34467240
Immunity. 2014 Apr 17;40(4):621-32
pubmed: 24745336
Mucosal Immunol. 2015 Nov;8(6):1388-99
pubmed: 25669147
J Infect Dis. 2015 Apr 1;211(7):1164-73
pubmed: 25336727
Cancer Gene Ther. 2006 Sep;13(9):819-29
pubmed: 16424918
Microbiol Spectr. 2015 Aug;3(4):
pubmed: 26350328
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
Sci Rep. 2018 Jul 20;8(1):11015
pubmed: 30030504
J Infect Dis. 2001 Mar 1;183 Suppl 1:S61-5
pubmed: 11171017
Front Pediatr. 2018 Oct 04;6:277
pubmed: 30356806
Am J Physiol Renal Physiol. 2003 Apr;284(4):F840-51
pubmed: 12620925
J Cell Sci. 2014 Jun 1;127(Pt 11):2383-90
pubmed: 24829146
J Infect Dis. 2000 Dec;182(6):1738-48
pubmed: 11069247
Infect Immun. 2003 Dec;71(12):7164-9
pubmed: 14638809
N Engl J Med. 2011 Jul 21;365(3):239-50
pubmed: 21774712
Annu Rev Immunol. 2009;27:519-50
pubmed: 19302047
PLoS One. 2012;7(5):e37689
pubmed: 22649552
J Urol. 2007 Mar;177(3):1102-6
pubmed: 17296422
Cell Mol Immunol. 2020 May;17(5):433-450
pubmed: 32238918

Auteurs

Daniel Butler (D)

Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.

Ines Ambite (I)

Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.

Murphy Lam Yim Wan (MLY)

Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.

Thi Hien Tran (TH)

Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.

Björn Wullt (B)

Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.

Catharina Svanborg (C)

Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden. catharina.svanborg@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH